Indane derivatives for use in the treatment of bacterial infection

The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Simon LEIRIS, Richard Leonard ELLIOTT, David Edward CLARK, THOMAS DAVID PALLIN, David Thomas DAVIES, Martin EVERETT, Lilha BEYRIA, Nicolas SPRYNSKI, Toby Jonathan BLENCH, Andrew Peter CRIDLAND
Format: Patent
Sprache:eng ; heb
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Simon LEIRIS
Richard Leonard ELLIOTT
David Edward CLARK
THOMAS DAVID PALLIN
David Thomas DAVIES
Martin EVERETT
Lilha BEYRIA
Nicolas SPRYNSKI
Toby Jonathan BLENCH
Andrew Peter CRIDLAND
description The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL281780A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL281780A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL281780A3</originalsourceid><addsrcrecordid>eNrjZHDyzEtJzEtVSEktyixLLMksSy1WSMsvUigtTlXIzFMoyUhVKClKTSzJTc0rUchPU0hKTC4BKk3MAcqmpSaXZObn8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeE8fIwtDcwsDR2OCCgAS_DDP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Indane derivatives for use in the treatment of bacterial infection</title><source>esp@cenet</source><creator>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</creator><creatorcontrib>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</creatorcontrib><description>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</description><language>eng ; heb</language><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210531&amp;DB=EPODOC&amp;CC=IL&amp;NR=281780A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210531&amp;DB=EPODOC&amp;CC=IL&amp;NR=281780A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Simon LEIRIS</creatorcontrib><creatorcontrib>Richard Leonard ELLIOTT</creatorcontrib><creatorcontrib>David Edward CLARK</creatorcontrib><creatorcontrib>THOMAS DAVID PALLIN</creatorcontrib><creatorcontrib>David Thomas DAVIES</creatorcontrib><creatorcontrib>Martin EVERETT</creatorcontrib><creatorcontrib>Lilha BEYRIA</creatorcontrib><creatorcontrib>Nicolas SPRYNSKI</creatorcontrib><creatorcontrib>Toby Jonathan BLENCH</creatorcontrib><creatorcontrib>Andrew Peter CRIDLAND</creatorcontrib><title>Indane derivatives for use in the treatment of bacterial infection</title><description>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDyzEtJzEtVSEktyixLLMksSy1WSMsvUigtTlXIzFMoyUhVKClKTSzJTc0rUchPU0hKTC4BKk3MAcqmpSaXZObn8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeE8fIwtDcwsDR2OCCgAS_DDP</recordid><startdate>20210531</startdate><enddate>20210531</enddate><creator>Simon LEIRIS</creator><creator>Richard Leonard ELLIOTT</creator><creator>David Edward CLARK</creator><creator>THOMAS DAVID PALLIN</creator><creator>David Thomas DAVIES</creator><creator>Martin EVERETT</creator><creator>Lilha BEYRIA</creator><creator>Nicolas SPRYNSKI</creator><creator>Toby Jonathan BLENCH</creator><creator>Andrew Peter CRIDLAND</creator><scope>EVB</scope></search><sort><creationdate>20210531</creationdate><title>Indane derivatives for use in the treatment of bacterial infection</title><author>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL281780A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Simon LEIRIS</creatorcontrib><creatorcontrib>Richard Leonard ELLIOTT</creatorcontrib><creatorcontrib>David Edward CLARK</creatorcontrib><creatorcontrib>THOMAS DAVID PALLIN</creatorcontrib><creatorcontrib>David Thomas DAVIES</creatorcontrib><creatorcontrib>Martin EVERETT</creatorcontrib><creatorcontrib>Lilha BEYRIA</creatorcontrib><creatorcontrib>Nicolas SPRYNSKI</creatorcontrib><creatorcontrib>Toby Jonathan BLENCH</creatorcontrib><creatorcontrib>Andrew Peter CRIDLAND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Simon LEIRIS</au><au>Richard Leonard ELLIOTT</au><au>David Edward CLARK</au><au>THOMAS DAVID PALLIN</au><au>David Thomas DAVIES</au><au>Martin EVERETT</au><au>Lilha BEYRIA</au><au>Nicolas SPRYNSKI</au><au>Toby Jonathan BLENCH</au><au>Andrew Peter CRIDLAND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Indane derivatives for use in the treatment of bacterial infection</title><date>2021-05-31</date><risdate>2021</risdate><abstract>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL281780A
source esp@cenet
title Indane derivatives for use in the treatment of bacterial infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Simon%20LEIRIS&rft.date=2021-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL281780A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true